首页|右美托咪定复合罗哌卡因行腹横肌平面阻滞辅助全身麻醉对肥胖症患者术后恢复的影响

右美托咪定复合罗哌卡因行腹横肌平面阻滞辅助全身麻醉对肥胖症患者术后恢复的影响

扫码查看
目的:探讨右美托咪定复合罗哌卡因行腹横肌平面阻滞(TAPB)辅助全身麻醉对肥胖症患者腹腔镜胃减容术后恢复的影响.方法:选取 2021 年 1 月至 2022 年 6 月在该院行腹腔镜减容术治疗的 115 例肥胖症患者进行前瞻性研究,按照随机数字表法将其分为研究组(n=58)和对照组(n=57).两组术中均采用常规静脉全身麻醉,在麻醉诱导完成后实施超声引导下双侧TAPB,对照组采用罗哌卡因行TAPB,研究组采用右美托咪定复合罗哌卡因行TAPB.比较两组麻醉恢复指标(唤醒时间、自主呼吸恢复时间及拔管时间)水平,术中舒芬太尼、丙泊酚用量,围术期[麻醉诱导完成后(T1)、术后即刻(T2)、拔管即刻(T3)、拔管10 min(T4)]平均动脉压(MAP)和心率水平,以及不良反应发生率.结果:研究组唤醒时间、自主呼吸恢复时间及拔管时间均短于对照组,差异有统计学意义(P<0.05);研究组术中舒芬太尼、丙泊酚用量均少于对照组,差异有统计学意义(P<0.05);T1 时,两组MAP、心率水平比较,差异均无统计学意义(P>0.05);T2、T3、T4 时,研究组MAP、心率水平均低于对照组,差异有统计学意义(P<0.05);研究组不良反应发生率为8.62%(5/58),低于对照组的 22.81%(13/57),差异有统计学意义(P<0.05).结论:右美托咪定复合罗哌卡因行TAPB辅助全身麻醉用于腹腔镜胃减容术治疗的肥胖症患者可减少静脉麻醉药物用量,缩短术后唤醒时间、自主呼吸恢复时间及拔管时间,降低不良反应发生率,维持术后血流动力学稳定,效果优于单用罗哌卡因行TAPB.
Effects of Dexmedetomidine combined with Ropivacaine for transversus abdominis plane block-assisted general anesthesia on postoperative recovery of obese patients
Objective:To investigate effects of Dexmedetomidine combined with Ropivacaine for transversus abdominis plane block(TAPB)-assisted general anesthesia on recovery of obese patients after laparoscopic vertical banded gastroplasty.Methods:A prospective study was conducted on 115 obese patients who underwent laparoscopic vertical banded gastroplasty in this hospital from January 2021 to June 2022.According to the random number table method,they were divided into study group(n=58)and control group(n=57).Conventional intravenous general anesthesia was used in both groups,and ultrasound-guided bilateral TAPB was performed after anesthesia induction.The control group was treated with Ropivacaine for TAPB,while the study group was treated with Dexmedetomidine combined with Ropivacaine for TAPB.The anesthesia recovery indexes(wake-up time,spontaneous breathing recovery time and extubation time),the dosage of Sufentanil and Propofol during the surgery,the mean arterial pressure(MAP)and heart rate during perioperative period[after anesthesia induction(T1),immediately after the surgery(T2),immediately after extubation(T3),10 min after extubation(T4)],and the incidence of adverse reactions were compared between the two groups.Results:The wake up time,the spontaneous breathing recovery time and the extubation time of the study group were shorter than those of the control group,and the differences were statistically significant(P<0.05).The dosage of Sufentanil and Propofol in the study group was less than that in the control group,and the difference was statistically significant(P<0.05).At T1,there were no significant differences in the MAP and the heart rate between the two groups(P>0.05).At T2,T3 and T4,the levels of MAP and heart rate in the study group were lower than those in the control group,and the differences were statistically significant(P<0.05).The incidence of adverse reactions in the observation group was 8.62%(5/58),which was lower than 22.81%(13/57)in the control group,and the difference was statistically significant(P<0.05).Conclusions:Dexmedetomidine combined with Ropivacaine for TAPB in the obese patients undergoing laparoscopic vertical banded gastroplasty can reduce the dosage of intravenous anesthetics,shorten the postoperative wake up time,the spontaneous breathing recovery time and the extubation time,reduce the incidence of adverse reactions,and maintain the postoperative hemodynamic stability.Moreover,it is superior to single Ropivacaine for TAPB.

DexmedetomidineRopivacaineTransversus abdominis plane blockObesityLaparoscopic vertical banded gastroplastyGeneral anesthesiaPostoperative recovery

颜朋朋、王军、李杏瑞

展开 >

洛阳市中医院麻醉科,河南 洛阳 471099

右美托咪定 罗哌卡因 腹横肌平面阻滞 肥胖症 腹腔镜胃减容术 全身麻醉 术后恢复

2024

中国民康医学
中国社会工作协会

中国民康医学

影响因子:0.649
ISSN:1672-0369
年,卷(期):2024.36(9)
  • 12